1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6117FCF134D27A5CB00258AA9002B6F6B
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-meeting-needs-of-payers-through-market-access-function-success-factors-pitfalls-resourcing-benchmarks?opendocument
18
19opendocument
2034.239.151.124
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Market Access Resource Benchmarks

Meeting the Needs of Payers Through the Market Access Function: Success Factors, Pitfalls, and Resourcing Benchmarks

ID: 5790


Features:

10 Info Graphics

6 Data Graphics

90+ Metrics

3 Narratives


Pages/Slides: 23


Published: 2024


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Meeting the Needs of Payers Through the Market Access Function: Success Factors, Pitfalls, and Resourcing Benchmarks”

STUDY OVERVIEW

In response to the escalating influence of payers in the healthcare industry, pharmaceutical companies are proactively establishing dedicated Market Access teams to elevate engagement. To maximize impact, Market Access leaders need to implement effective strategies, encompassing optimized resource allocation, identification of key stakeholders, and selection of appropriate tactics.

Best Practices, LLC conducted benchmarking research to unveil best-in-class strategies that enhance operational performance and amplify payer engagement. This study empowers Market Access leaders with nuanced insights into success factors, pitfalls, and investment benchmarks, enabling them to navigate challenges and optimize resource utilization for sustained success.

KEY TOPICS

  • Market Access Staffing and Investment Benchmarks
  • Major Pitfalls Encountered by Market Access Groups
  • Success Factors for Market Access
  • Payer Engagement Success Factors

KEY METRICS

  • Annual budget of the Market Access function
  • Number of payer meetings held by one Market Access associate or representative; Number of Market Access representatives brought in on each payer meeting
  • Market Access sub-function spending breakdown
  • Current headcount for each operational role within the Market Access function
  • Additional FTEs needed within each operational role to optimize Market Access performance

SAMPLE KEY FINDINGS

  • Long-Term Success Factors for Market Access: Better pricing strategy, proactive strategy, improved tracking of execution, and enhanced omnichannel engagement strategy.

METHODOLOGY

Best Practices, LLC engaged 11 Market Access leaders across diverse biopharma organizations in this benchmarking research.

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Market Research


Companies Profiled:
AbbVie; Alkermes; Bayer; Boehringer Ingelheim; F2G - The Rare Fungal Disease Company; Ferring Pharmaceuticals; Health Industries Research Companies (HIRC); Idorsia; Ipsen; Jazz Pharmaceuticals; UCB Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.